After years of watching employers pour money into telemedicine platforms, I've noticed something uncomfortable: most of them aren't saving a dime. They add a virtual care option, employees use it, satisfaction scores go up, and yet healthcare costs keep climbing. The same thing happens with in-person care, only slower.
The problem is the system, not the modality. The real battle is between a system designed to process claims and a system designed to build lasting value. A screen versus an exam table is a side detail. And almost nobody in the benefits world is talking about that.
Two models, one flaw
Let's look at what both telemedicine and in-person visits do for an employer's bottom line. In both cases, the employee gets sick, sees a clinician, and generates a claim. The telemedicine version might be cheaper per visit, say $50 instead of $150, but employees use it more often. A RAND analysis of commercial claims found that 88 percent of direct-to-consumer telehealth visits for acute respiratory illness were new utilization rather than substitutes for an office visit, and net annual spending rose $45 per user. The net effect on total spend is flat.
In-person care is worse. The average office visit involves scheduling friction, a 15-minute consultation, and a claims event that drives up next year's premiums. The physician gets paid for volume, not for keeping anyone healthy. Prevention is an afterthought.
Both models are built to complete episodes: treat the symptom, close the chart, move on. Neither is built to improve the system: reduce future risk, reward healthy behavior, connect care to long-term wealth.
The hidden yardstick nobody uses
Instead of comparing telemedicine and in-person on cost per visit or satisfaction, I use a different lens. Ask yourself: Does this encounter generate structured, actionable data that can be linked to preventive behavior, retirement funding, and lower employer costs?
Apply that lens:
- In-person visit: Free-text notes, billing codes. No behavior signal. No reward linkage. Pure claim event.
- Standard telemedicine: Visit summary, prescription code. Still no behavior signal. Still no reward linkage. Still a claim event.
- Prevention-first system: Standardized preventive code plus plan-of-care update. Positive behavior signal. Instant reward dollars and an automatic retirement contribution. Zero claims drag.
The difference is structural.
What the numbers say
Here is the math for a 500-employee company:
- About 300 aren't completing recommended preventive care.
- Those 300 generate around 700 sick visits per year at an average of $200 each, or $140,000.
- Chronic disease from delayed care adds another $400,000+ in claims annually.
A standard telemedicine vendor might reduce the cost of those sick visits by 30%, saving $42,000. Nice, but it's a rounding error on total spend.
Now imagine a system that gets 80% of those 300 people into preventive screenings before they get sick. No new claims from those visits (prevention is covered at $0 copay). The $540,000 in avoidable costs starts shrinking because people catch issues early. Employees earn real, spendable rewards and watch their retirement accounts grow. And after six to twelve months, the system generates a WellthCare Readiness Index™ that identifies which employees should move to Medicare, cutting employer claims for each person who transitions.
That is a change to the structure of total cost of care, which a 30% discount on a single visit type never delivers.
So what should you ask your vendors?
If you're evaluating a telemedicine or care delivery solution right now, set aside visit volumes and patient satisfaction and ask these four questions:
- Does your platform generate a structured, verifiable prevention signal? If not, you're buying a digital clinic, not a system improvement.
- Is the data from this encounter usable for behavior-based rewards? If not, you have no engagement loop. Employees will use it once and forget it.
- Can you identify which employees are ready to move to Medicare? If not, you're leaving the biggest cost-reduction lever untouched.
- Does using your service demonstrably lower next year's premiums? If the answer is "we help manage utilization," that's not the same thing.
The vendors who can answer yes to all four are rare. The ones who can't are competing on convenience alone, and convenience is a commodity.
What telemedicine is still good for
None of this means employers should cancel their telemedicine vendor. The same RAND analysis that found higher net spending also found telehealth made care easier to reach, especially outside business hours. Access has value. The mistake is expecting an access tool to do a cost-control job.
Telemedicine earns its keep when it removes friction from follow-ups, refills, and minor concerns that would otherwise become an urgent care trip at 9 p.m. Where it fails is as a spending strategy: a cheaper visit that happens more often does not shrink the total bill, and the 88 percent new-utilization finding is the evidence. Keep the convenience. Don't book the savings.
The bottom line
The telemedicine versus in-person debate is a distraction. Both are delivery mechanisms. Neither solves the core problem: healthcare is a cost center that rewards sickness and ignores behavior.
The next generation of benefits will be judged by whether the system employees use turns their health actions into wealth, automatically, transparently, and at scale. Where they sit when they talk to a doctor matters less. WellthCare™, the first Health-to-Wealth™ Benefit System, is built to deliver that, rewarding every verified preventive health action with earned store dollars and automatic retirement contributions while lowering employer claims with zero disruption.
Stop counting visits and start designing systems.
Employers who figure this out first save money. They also build a workforce that's healthier, wealthier, and more loyal, because their benefits work.